Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

ADAM15 mediates upregulation of Claudin-1 expression in breast cancer cells

Mattern, Jens, Roghi, Christian S., Hurtz, Melanie, Knauper, Vera ORCID:, Edwards, Dylan R. and Poghosyan, Zaruhi ORCID: 2019. ADAM15 mediates upregulation of Claudin-1 expression in breast cancer cells. Scientific Reports 9 (1) , 12540. 10.1038/s41598-019-49021-3

[thumbnail of s41598-019-49021-3.pdf]
PDF - Published Version
Available under License Creative Commons Attribution.

Download (3MB) | Preview
[thumbnail of 125237 supplement.pdf]
PDF - Supplemental Material
Download (2MB) | Preview


A Disintegrin and Metalloproteinase-15 (ADAM15) is a transmembrane protein involved in protein ectodomain shedding, cell adhesion and signalling. We previously cloned and characterised alternatively spliced variants of ADAM15 that differ in their intracellular domains and demonstrated correlation of the expression of specific variants with breast cancer prognosis. In this study we have created isogenic cell panels (MDA-MB-231 and MCF-7) expressing five ADAM15 variants including wild-type and catalytically inactive forms. The expression of ADAM15 isoforms in MDA-MB-231 cells led to cell clustering to varying degree, without changes in EMT markers vimentin, slug and E-cadherin. Analysis of tight junction molecules revealed ADAM15 isoform specific, catalytic function dependent upregulation of Claudin-1. The expression of ADAM15A, and to a lesser degree of C and E isoforms led to an increase in Claudin-1 expression in MDA-MB-231 cells, while ADAM15B had no effect. In MCF-7 cells, ADAM15E was the principal variant inducing Claudin-1 expression. Sh-RNA mediated down-regulation of ADAM15 in ADAM15 over-expressing cells reduced Claudin-1 levels. Additionally, downregulation of endogenous ADAM15 expression in T47D cells by shRNA reduced endogenous Claudin-1 expression confirming a role for ADAM15 in regulating Claudin-1 expression. The PI3K/Akt/mTOR pathway was involved in regulating Claudin-1 expression downstream of ADAM15. Immunofluorescence analysis of MDA-MB-231 ADAM15A expressing cells showed Claudin-1 at cell-cell junctions, in the cytoplasm and nuclei. ADAM15 co-localised with Claudin-1 and ZO1 at cell-cell junctions. Immunoprecipitation analysis demonstrated complex formation between ADAM15 and ZO1/ZO2. These findings highlight the importance of ADAM15 Intra Cellular Domain-mediated interactions in regulating substrate selection and breast cancer cell phenotype.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Dentistry
Publisher: Nature Publishing Group
ISSN: 2045-2322
Date of First Compliant Deposit: 3 September 2019
Date of Acceptance: 19 August 2019
Last Modified: 28 May 2023 20:41

Citation Data

Cited 10 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item


Downloads per month over past year

View more statistics